Trial record 1 of 1 for:    MM08-141
Previous Study | Return to List | Next Study

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Hoosier Cancer Research Network
Sponsor:
Collaborators:
Hoosier Cancer Research Network
Cephalon
Information provided by (Responsible Party):
Sherif Farag, MB, BS, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT01177683
First received: August 5, 2010
Last updated: March 13, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)